Mycobacterium tuberculosis infection of a native polycystic kidney following renal, transplantation

Transplantation

Volumn 66, Issue 1, 1998, Pages 118-120

  Klemperer, John D ^a   Wang, John ^a   Hartman, Barry J ^a   Stubenbord, William T ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TUBERCULOSIS;

FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; NEPHRECTOMY; POLYCYSTIC KIDNEY DISEASES; REOPERATION; TUBERCULOSIS, UROGENITAL;

EID: 0032528269     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807150-00019     Document Type: Article

References (13)

1. Sklar AH, Caruana RJ, Lammers JE, Strauser GD. Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987; 10: 81.
2. Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med 1986; 82: 714.
3. Fitzpatrick PM, Torres VE, Charboneau JW, Oford KP, Holley KE, Zincke H. Long-term outcome of renal transplantation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1990; 15: 535.
4. Wallenius M, Kuhlback B, Brotherus JW. Renal transplantation in polycystic kidney disease. Scand J Urol Nephrol 1978; 12: 75.
5. United States Renal Data System. 1996 Annual data report. Rockville, MD: U.S. Department of Health and Human Services Health Care Financing Administration Bureau of Data Management and Safety.
6. Sweet R, Keane WF. Perinephric abscess in patients with polycystic kidney disease undergoing chronic hemodialysis. Nephron 1979; 23: 237.
7. Bennet WM, Elzinga L, Pulliam JP, Rashad AL, Bary JM. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis 1985; 6: 400.
8. Schwab SJ, Weaver ME. Penetration of trimethoprim and sulfamethoxazole into cysts in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 1986; 7: 434.
9. Rayner BL, Cassidy JD, Jacobsen JE, Pascoe MD, Pontin AR, van Zyl Smit R. Is preliminary binephrectomy necessary in patients with autosomal dominant polycystic kidney disease undergoing renal transplantation? Clin Nephrol 1990; 34: 122.
10. Mendelssohn DC, Harding ME, Cardella CJ, Cook GT, Uldall PR. Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation. Clin Nephrol 1988; 30: 315.
11. Aguado JM, Herrero JA, Gavald J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation 1997; 63: 1278.
12. Tantawichien T, Suwangool P, Suvanapha R. Tuberculosis in renal transplant recipients. Transplant Proc 1994; 26: 2187.
13. Al-Sulaiman MH, Dhar JM, Al-Hasani MK, Hallem A, AlKhader AA. Tuberculous interstitial nephritis after kidney transplantation. Transplantation 1990; 50: 162.